Product Images Levetiracetam
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Levetiracetam NDC 15955-327 by Orit Laboratories Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Chemical Structure - levetiracetam 01
Figure 1 - levetiracetam 02
This document appears to be an excerpt from a clinical trial study, presenting some data related to the patients and their prescription drugs. The given table shows the number of patients who received a placebo treatment and the number of patients who were administered Levetiracetam, which is an anticonvulsant drug. The data is divided based on the drug dosage, which is 1000mg/day and 3000mg/day. However, given the shortness and lack of context of this text, it is not possible to infer any further information.*
Figure 2 - levetiracetam 03
This appears to be a chart or graph displaying percentages of patients for a study involving a placebo group and two different dosages of a medication called Levetiracetam. The percentages may represent the number of patients who responded positively to the treatment at each dosage level. However, without more context it is difficult to say for certain.*
Figure 3 - levetiracetam 04
The given text provides information about the percentage of patients in two different groups: Placebo and Levetiracetam. However, the specific details of the groups and their conditions have not been given. The percentage of patients is mentioned for the two groups as 14.4% and 39.4%, respectively. Additionally, it is noted that the number of patients in the Placebo group is 104 and that in the Levetiracetam group is 180. It seems that this text may represent data from a research study or clinical trial, but without additional information, further interpretation of the text is not possible.*
Figure 4 - levetiracetam 05
This appears to be a table with three columns, displaying percentages. There are two rows and the first row has the heading "% of Patients" while the second row has "%", "Placebo (N=97)", and "Levetiracetam (N=101)" in separate columns. Unfortunately, there isn't enough context to know what the percentages refer to.*
Figure 6 - levetiracetam 06
PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label - levetiracetam 07
Levetiracetam USP is an oral solution with a concentration of 100mg/mL. The package insert should be consulted for recommended dosage. The medication should be stored in a tightly sealed, light-resistant container at a temperature between 20°C and 25°C. Levetiracetam is manufactured by Silrx Pharmaceuticals, Inc. and distributed by Orit Laboratories LLC. This product should be dispensed with a medication guide and kept away from children. No further information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.